Elsevier Health and OpenEvidence collaborated in the development of ClinicalKey AI with input from Cone Health, University of New Mexico and more than 30,000 physicians from across the US. New York, ...

Elsevier Health has launched an generative AI-driven version of its flagship clinical decision support tool, ClinicalKey, in partnership with AI company OpenEvidence. The latest add-on module offers ...

ClinicalKey AI now includes full-text content from premium journals and medical organizations such as The Lancet, the New England Journal of Medicine (NEJM), the European Society For Medical Oncology ...

Elsevier Health is offering ClinicalKey AI, a clinical decision support tool that combines the latest medical content with generative artificial intelligence to help clinicians at the point of care.

LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital ...

New functionality and partnerships make it easier for clinicians to access crucial information at the point of care and log learning credits. NEW YORK, March 3, 2025 /PRNewswire/ -- Elsevier, a global ...

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has launched a ClinicalKey mobile app that enables rapid access to evidence-based, peer ...

Elsevier, which provides medical content and solutions, has launched ClinicalKey, the next generation of online clinical information resources. It draws answers from the largest collection of clinical ...

Incorporating extensive physician feedback, enhanced ClinicalKey supports a range of uses, from 'quick check' searches to 'short confirmations' and deeper research Elsevier, a world-leading provider ...

Elsevier, the global information analytics business specializing in science and health, and part of RELX Group, today announced the launch of its new medical learning platform, ClinicalKey Medical ...

ClinicalKey AI now includes full-text content from premium journals and medical organizations such as The Lancet, the New England Journal of Medicine (NEJM), the European Society For Medical Oncology ...